U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Blood & Blood Products
  4. Approved Blood Products
  5. Alphanate
  1. Approved Blood Products

STN: BL 102475
Proper Name: Antihemophilic Factor/von Willebrand Factor Complex (Human)
Tradename: Alphanate
Manufacturer: Grifols Biologicals Inc, License #1694
Indication: 

  • Control and prevention of bleeding in patients with hemophilia A or acquired Factor VIII (FVIII) deficiency (1.1)
  • Surgical and/or invasive procedures in adult and pediatric patients with von Willebrand Disease in whom desmopressin (DDAVP) is either ineffective or contraindicated. It is not indicated for patients with severe VWD (Type 3) undergoing major surgery (1.2)

Product Information

Supporting Documents

Back to Top